Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB) -- Ignore unavailable to you. Want to Upgrade?

To: Glenn McDougall who wrote (52)	5/29/1998 2:36:00 PM
From: don jackson	Read Replies (1) \| Respond to of 236

Glenn, I'm not sure whether this will have a great effect currently as the markets externals (e.g. asian & Japanese currencies/markets) will probably dictate what happens with SSB (i.e. we will probably see the stock become more volatile). However the issue will provide for longer term financing to see some of their products into trials or at least closer to them. So that's a positive anyways. In terms of it being another way of picking up the stock, I think we will have to wait and see. If the market drops you may be able to pick up SSB more cheaply regardless. Anyways it is clearly a longer term investment. --don--